3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Active not recruiting
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
62
Carcinoma, Non-Small-Cell Lung
45
Triple Negative Breast Neoplasms
24
Ovarian Neoplasms
20
Fallopian Tube Neoplasms
17
Lung Neoplasms
16
Neoplasm Metastasis
15
Endometrial Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
14
Stomach Neoplasms
12
Esophageal Neoplasms
10
Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Esophageal Squamous Cell Carcinoma
8
Colorectal Neoplasms
7
Inflammatory Breast Neoplasms
6
Head and Neck Neoplasms
6
Uterine Cervical Neoplasms
5
Carcinoma, Ovarian Epithelial
5
Carcinoma
5
Melanoma
4
Carcinoma, Transitional Cell
4
Carcinoma, Squamous Cell
4
Adenocarcinoma Of Esophagus
4
Urinary Bladder Neoplasms
3
Peritoneal Neoplasms
3
Pancreatic Neoplasms
3
Oropharyngeal Neoplasms
3
Mouth Neoplasms
3
Lung Diseases
3
Interventions
Surgical Procedures, Operative
2
Paclitaxel
2
Doxorubicin
2
Cyclophosphamide
2
Carboplatin
2
pertuzumab
1
liposomal doxorubicin
1
cemiplimab
1
atezolizumab
1
Trastuzumab
1
Radiotherapy
1
Indocyanine Green
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Invasive Breast Cancer
×
Paclitaxel
×
Clear all
NCT04243616
2025-09-05
CemiHALT
Medical College of Wisconsin
Phase 2
Active not recruiting
36 enrolled
NCT03595592
2024-03-06
APTneo
Fondazione Michelangelo
Phase 3
Active not recruiting
650 enrolled